“We wondered, was that only a U.S. phenomenon?” Novo Nordisk CEO Lars Fruergaard Jørgensen said on the demand for weight-loss drugs in Europe. Read More
Recent Posts
- Companies need to fortify supply chains for “a flock of black swan” events, says Toll Group executive chairman Thomas Knudsen
- Prime Infra’s CEO says the Paris 1.5-degree goal is ‘feasible’ for Southeast Asia—if governments are willing to pay for it
- How the Democratic party flipped the House and Senate, in 12 charts
- Ken Griffin and Jeff Bezos helped make Miami a billionaire magnet—but Florida’s new $250,000 homestead exemption barely makes a dent for them
- I believe in AI. But my AI assistant gave me more work than it could finish
Archives
- November 2026
- October 2026
- September 2026
- August 2026
- July 2026
- June 2026
- May 2026
- April 2026
- March 2026
- February 2026
- January 2026
- December 2025
- November 2025
- October 2025
- September 2025
- August 2025
- July 2025
- June 2025
- May 2025
- April 2025
- March 2025
- February 2025
- January 2025
- December 2024
- November 2024
- October 2024
- September 2024
- August 2024
- February 2024
- January 2024
- December 2023
- November 2023
- October 2023
- September 2023
- August 2023
- July 2023
- June 2023
- May 2023
- April 2023
- March 2023
- February 2023
- January 2023
- December 2022
- November 2022
- October 2022
- September 2022
- August 2022
- July 2022
- June 2022
- May 2022
- April 2022
Recent Comments